Lifestyle

Eli Lilly announced it needed to work a few more years on its Alzheimer's drug, causing its stock to drop. Meanwhile, Johnson & Johnson got a needed nod of approval for its underappreciated pharmaceutical division.

Most physicians will say they're putting more time and effort into their medical practice than 10 or 15 years ago. But the important question is whether or not that extra time it used profitably. Unfortunately, they don't often know.

Usually in December, companies that have had a tough year are sold off in order to use the tax losses to offset gains. However, despite Apple's terrible two months, the pressure may be coming to an end because of the "wash sale" rule.

Given current numbers and health care industry forecasts, such as the implementation of the Affordable Care Act and possible Medicare spending cuts, the number of medical offices accepting Medicare and Medicaid may decline.

One of the gaping holes in our national struggles with reducing the costs of health care is the limited emphasis upon wellness. Plus, Congressional insider trading, researching charities before donating and the U.S. fiscal union as "an engine of subsidy."

HIT is ever-growing, but it still has a ways to go. With 2013 around the corner, now is the time to consider your HIT resolutions for the New Year.

The unemployment rate remains a concern for investors and the Federal Reserve, which just announced interest rates will stay near zero until unemployment falls to 6.5%. If you're concerned as well, here are the 10 metro areas with the lowest unemployment rates.

A proposed act in Congress would create new a Office of Wireless Health Technology within the FDA to advance the health information technology sector with financial incentives, grants and workforce development programs.

With the pressures of the holidays, a growing probability of going over the fiscal cliff and weak job security, a good New Year's resolution for many might be to schedule a stress test for your portfolio.

Customer satisfaction with credit cards has been fairly high since the recession, but will that hold true in the new year? Here are five educated guesses about the state of credit in 2013.

10 Stocks for 2013

Barron's list of top 10 stocks for 2013 includes big names like Apple and JPMorgan. Plus, we look at last year's list to see how those stocks did.

The cost of drug development has been a matter of controversy, particularly because the high cost and long time to bring a drug from discovery to market is used to justify high prices for innovative drugs.

The generic drug industry is dancing on the edge of a generic cliff. Plus, as the U.S. gets closer to going over the fiscal cliff, Japan reported falling into a recession, China's exports fell and Germany cut growth forecasts.

There has been a drastic shift in priorities for physicians over the last few decades. Now they're willing to earn less if it means less hours and more time at home with the family.

The fiscal cliff situation and possible huge increase to the dividend tax has certainly impacted investors that have a dividend focus. What is an investor to do if they want to capture high yields while avoiding the tax increase?

The work-life balance conundrum affects every living soul. If doctors are to hope for any chance at an alleged work-life balance in medicine, they first must confront and manage any guilt they might have about time away from journals and patients

Perhaps it's the fiscal cliff and the seemingly stalled talks between Democrats and Republicans, but business executives have a poor outlook for the U.S. economy, according to a new survey.